Regulation of dopamine receptor sensitivity by an endogenous protein activator or adenylate cyclase
- 1 January 1977
- journal article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 297 (S1), S47-S48
- https://doi.org/10.1007/bf00587774
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic DrugsScience, 1976
- Regulation of transsynaptically elicited increase of 3':5'-cyclic AMP by endogenous phosphodiesterase activator.Proceedings of the National Academy of Sciences, 1976
- Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine NeuronsScience, 1975
- Identification of a calcium-binding protein as a calcium-dependent regulator of brain adenylate cyclase.Proceedings of the National Academy of Sciences, 1975
- Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholaminesNeuropharmacology, 1974
- Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the “dopamine receptor”Proceedings of the National Academy of Sciences, 1972
- Cyclic 3',5'-nucleotide phosphodiesterase. Evidence for and properties of a protein activator.1971
- Cyclic 3',5'-Nucleotide PhosphodiesterasePublished by Elsevier ,1971
- Adenyl Cyclase Activity in Rat Pineal Gland: Effects of Chronic Denervation and NorepinephrineScience, 1967